These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Adding lamotrigine to valproate: incidence of rash and other adverse effects. Postmarketing Antiepileptic Drug Survey (PADS) Group. Faught E; Morris G; Jacobson M; French J; Harden C; Montouris G; Rosenfeld W Epilepsia; 1999 Aug; 40(8):1135-40. PubMed ID: 10448828 [TBL] [Abstract][Full Text] [Related]
3. Correlating lamotrigine serum concentrations with tolerability in patients with epilepsy. Hirsch LJ; Weintraub D; Du Y; Buchsbaum R; Spencer HT; Hager M; Straka T; Bazil CW; Adams DJ; Resor SR; Morrell MJ Neurology; 2004 Sep; 63(6):1022-6. PubMed ID: 15452293 [TBL] [Abstract][Full Text] [Related]
4. Safety of lamotrigine. Richens A Epilepsia; 1994; 35 Suppl 5():S37-40. PubMed ID: 8039469 [TBL] [Abstract][Full Text] [Related]
5. Safety of long-term lamotrigine in epilepsy. Mackay FJ; Wilton LV; Pearce GL; Freemantle SN; Mann RD Epilepsia; 1997 Aug; 38(8):881-6. PubMed ID: 9579888 [TBL] [Abstract][Full Text] [Related]
6. Adverse event monitoring in lamotrigine patients: a pharmacoepidemiologic study in the United Kingdom. Wong IC; Mawer GE; Sander JW Epilepsia; 2001 Feb; 42(2):237-44. PubMed ID: 11240596 [TBL] [Abstract][Full Text] [Related]
9. Overview of lamotrigine and the new antiepileptic drugs: the challenge. Pellock JM J Child Neurol; 1997 Nov; 12 Suppl 1():S48-52. PubMed ID: 9429131 [TBL] [Abstract][Full Text] [Related]
10. Lamotrigine high-dose tolerability and safety in patients with epilepsy: a double-blind, placebo-controlled, eleven-week study. Matsuo F; Gay P; Madsen J; Tolman KG; Rollins DE; Risner ME; Lai AA Epilepsia; 1996 Sep; 37(9):857-62. PubMed ID: 8814098 [TBL] [Abstract][Full Text] [Related]
11. Carbamazepine toxicity with lamotrigine: pharmacokinetic or pharmacodynamic interaction? Besag FM; Berry DJ; Pool F; Newbery JE; Subel B Epilepsia; 1998 Feb; 39(2):183-7. PubMed ID: 9577998 [TBL] [Abstract][Full Text] [Related]
12. Lamotrigine: a review of antiepileptic efficacy. Yuen AW Epilepsia; 1994; 35 Suppl 5():S33-6. PubMed ID: 8039468 [TBL] [Abstract][Full Text] [Related]
13. Lamotrigine adjunctive therapy in childhood epileptic encephalopathy (the Lennox Gastaut syndrome). Donaldson JA; Glauser TA; Olberding LS Epilepsia; 1997 Jan; 38(1):68-73. PubMed ID: 9024186 [TBL] [Abstract][Full Text] [Related]
14. Lamotrigine versus other antiepileptic drugs: a star rating system is born. Brodie MJ Epilepsia; 1994; 35 Suppl 5():S41-6. PubMed ID: 8039470 [TBL] [Abstract][Full Text] [Related]
15. Adverse effects of carbamazepine, phenytoin, valproate and lamotrigine monotherapy in epileptic adult Chinese patients. Zeng K; Wang X; Xi Z; Yan Y Clin Neurol Neurosurg; 2010 May; 112(4):291-5. PubMed ID: 20071075 [TBL] [Abstract][Full Text] [Related]
16. Predictors of Lamotrigine-associated rash. Hirsch LJ; Weintraub DB; Buchsbaum R; Spencer HT; Straka T; Hager M; Resor SR Epilepsia; 2006 Feb; 47(2):318-22. PubMed ID: 16499755 [TBL] [Abstract][Full Text] [Related]
17. Human safety of lamotrigine. Betts T; Goodwin G; Withers RM; Yuen AW Epilepsia; 1991; 32 Suppl 2():S17-21. PubMed ID: 1837776 [TBL] [Abstract][Full Text] [Related]
18. Prospective, open-label, add-on study of lamotrigine in 56 children with intractable generalized epilepsy. Farrell K; Connolly MB; Munn R; Peng S; MacWilliam LM Pediatr Neurol; 1997 Apr; 16(3):201-5. PubMed ID: 9165509 [TBL] [Abstract][Full Text] [Related]
19. How to replace lamotrigine with valproate. Steinhoff BJ Epilepsia; 2006 Nov; 47(11):1943-4. PubMed ID: 17116036 [TBL] [Abstract][Full Text] [Related]
20. The efficacy of valproate-lamotrigine comedication in refractory complex partial seizures: evidence for a pharmacodynamic interaction. Pisani F; Oteri G; Russo MF; Di Perri R; Perucca E; Richens A Epilepsia; 1999 Aug; 40(8):1141-6. PubMed ID: 10448829 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]